Beverly Goulet
Fortune : 931 813 $ au 31/08/2026
Fortune : 931 813 $ au 31/08/2026
Beverly K.
Goulet is currently Chairman at Answer Als.
Serving as Independent Non-Executive Director at Rolls-Royce Holdings Plc since 2017.
Director at Rolls-Royce North America Holdings, Inc. since 2017.
Independent Director at Xenia Hotels & Resorts, Inc. since 2015.
Non-Executive Director at Rolls-Royce Plc since 2017.
Director at Dallas Women's Foundation.
Formerly Chairman at American Airlines Federal Credit Union.
Director at Yellow Corp.
from 2010 to 2011.
Independent Director at Atlas Air Worldwide Holdings, Inc. from 2021 to 2023.
Chief Restructuring Officer at AMR Corp.
Associate General Counsel at American Airlines, Inc. from 1993 to 2017.
Chief Integration Officer & Executive VP at American Airlines Group, Inc. from 2013 to 2017.
Educated at the University of Michigan with undergraduate and graduate degrees.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/06/2026 | 41 565 ( 0 % ) | 863 376 $ | 31/08/2026 | |
| 14/05/2026 | 3 650 ( 0 % ) | 68 438 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| XENIA HOTELS & RESORTS, INC. | Directeur/Membre du Conseil | 03/02/2015 |
| ROLLS-ROYCE HOLDINGS PLC | Directeur/Membre du Conseil | 03/07/2017 |
Rolls-Royce Plc
Rolls-Royce Plc Aerospace & DefenseElectronic Technology Manufactures aircraft, marine and generator power systems | Directeur/Membre du Conseil | 03/07/2017 |
Dallas Women's Foundation | Directeur/Membre du Conseil | - |
Rolls-Royce North America Holdings, Inc.
Rolls-Royce North America Holdings, Inc. Aerospace & DefenseElectronic Technology Manufactures power system that are used in aerospace, naval marine, energy and off-highway applications | Directeur/Membre du Conseil | 01/10/2017 |
Answer Als
Answer Als Answer ALS is a collaborative research initiative dedicated to accelerating the discovery of treatments and cures for amyotrophic lateral sclerosis (ALS), a progressive and fatal neurodegenerative disease affecting motor neurons. The private company is based in New Orleans, WI. The organization emphasizes open, transparent, and large-scale collaboration among academic institutions, pharmaceutical companies, and advocacy groups. Central to its efforts is NeuroMine, an open-access data platform that integrates multi-omics datasets—including genomics, transcriptomics, proteomics, epigenomics, and induced pluripotent stem cell (iPSC)-derived motor neuron data—from over 1,000 participants. This resource supports independent research projects worldwide by providing harmonized clinical, biological, and cellular data. The initiative has generated participant-derived iPSC lines through partnerships with centers such as the Cedars-Sinai Biomanufacturing Center, enabling scalable production of patient-specific motor neurons for disease modeling and drug discovery. Answer ALS’s research approach integrates advanced analytics, machine learning, and standardized clinical evaluations to uncover ALS subtypes, identify biomarkers and risk factors, and accelerate therapeutic breakthroughs. Ongoing connected studies continue to expand data and insights, and the organization investigates elevated ALS risk in specific populations such as military veterans and athletes. Beyond research, Answer ALS engages the public through educational resources, community involvement, fundraising campaigns, merchandise sales, and social media outreach. | Président | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ATLAS AIR WORLDWIDE HOLDINGS, INC. | Directeur/Membre du Conseil | 01/03/2023 |
| AMERICAN AIRLINES GROUP INC. | Corporate Officer/Principal | 01/06/2017 |
American Airlines, Inc.
American Airlines, Inc. AirlinesTransportation Provides scheduled passenger airline transportation services | Corporate Officer/Principal | 01/01/2017 |
| ░░░░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 13 |
|---|---|
American Airlines, Inc.
American Airlines, Inc. AirlinesTransportation Provides scheduled passenger airline transportation services | Transportation |
AMR Corp.
AMR Corp. AirlinesTransportation Provides scheduled passenger, freight and mail services | Transportation |
Yellow Corp.
Yellow Corp. TruckingTransportation Provides transportation, freight forwarding and logistics management services | Transportation |
Atlas Air Worldwide Holdings, Inc.
Atlas Air Worldwide Holdings, Inc. AirlinesTransportation Provides airfreight services | Transportation |
Rolls-Royce Holdings Plc
Rolls-Royce Holdings Plc Aerospace & DefenseElectronic Technology Manufactures aircraft, marine and generator power systems | Electronic Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Airlines Federal Credit Union
American Airlines Federal Credit Union Savings BanksFinance Operates as a credit union | Finance |
Rolls-Royce North America Holdings, Inc.
Rolls-Royce North America Holdings, Inc. Aerospace & DefenseElectronic Technology Manufactures power system that are used in aerospace, naval marine, energy and off-highway applications | Electronic Technology |
Xenia Hotels & Resorts, Inc.
Xenia Hotels & Resorts, Inc. Real Estate Investment TrustsFinance Operates as real estate investment trust which provides hotel and resort services | Finance |
Rolls-Royce Plc
Rolls-Royce Plc Aerospace & DefenseElectronic Technology Manufactures aircraft, marine and generator power systems | Electronic Technology |
Dallas Women's Foundation | |
American Airlines Group, Inc.
American Airlines Group, Inc. AirlinesTransportation Provides air transportation services for passengers and cargo | Transportation |
Answer Als
Answer Als Answer ALS is a collaborative research initiative dedicated to accelerating the discovery of treatments and cures for amyotrophic lateral sclerosis (ALS), a progressive and fatal neurodegenerative disease affecting motor neurons. The private company is based in New Orleans, WI. The organization emphasizes open, transparent, and large-scale collaboration among academic institutions, pharmaceutical companies, and advocacy groups. Central to its efforts is NeuroMine, an open-access data platform that integrates multi-omics datasets—including genomics, transcriptomics, proteomics, epigenomics, and induced pluripotent stem cell (iPSC)-derived motor neuron data—from over 1,000 participants. This resource supports independent research projects worldwide by providing harmonized clinical, biological, and cellular data. The initiative has generated participant-derived iPSC lines through partnerships with centers such as the Cedars-Sinai Biomanufacturing Center, enabling scalable production of patient-specific motor neurons for disease modeling and drug discovery. Answer ALS’s research approach integrates advanced analytics, machine learning, and standardized clinical evaluations to uncover ALS subtypes, identify biomarkers and risk factors, and accelerate therapeutic breakthroughs. Ongoing connected studies continue to expand data and insights, and the organization investigates elevated ALS risk in specific populations such as military veterans and athletes. Beyond research, Answer ALS engages the public through educational resources, community involvement, fundraising campaigns, merchandise sales, and social media outreach. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national